CG
CRNX icon

Cutler Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Cutler Group’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,200
Closed -$42K – 1054
2023
Q4 		$42K Sell
1,200
-3,600
-75% -$126K ﹤0.01% 695
2023
Q3 		$142K Buy
+4,800
New +$142K 0.01% 473